CIK: 1422304 - Address: C/O Apogee Therapeutics, Inc., 221 Crescent St., Bldg. 17, Ste. 102B, Waltham, MA 02453
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
12/5/25 20:02
12/4/25
APGEApogee Therapeutics, Inc.HealthBioPrdBiological Products, (No DiagHenderson JaneMAOCFOS-11375.000-2-1195D
11/28/25 20:00
11/25/25
APGEApogee Therapeutics, Inc.HealthBioPrdBiological Products, (No DiagHenderson JaneMAOCFOS-10570.000-2-1196D
11/14/25 20:00
11/14/25
APGEApogee Therapeutics, Inc.HealthBioPrdBiological Products, (No DiagHenderson JaneMAOCFOS-13065.000-2-1198D
11/13/25 20:37
11/11/25
APGEApogee Therapeutics, Inc.HealthBioPrdBiological Products, (No DiagHenderson JaneMAOCFOS-6060.000-10200D
8/12/25 20:32
8/12/25
AKROAkero Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHenderson JaneCADM.d217.0103479D
8/12/25 20:32
8/12/25
AKROAkero Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHenderson JaneCADS.d-14247.460-3-249D
8/23/24 20:05
8/23/24
APGEApogee Therapeutics, Inc.HealthBioPrdBiological Products, (No DiagHenderson JaneMAOCFOS-29048.260-6-3201D
6/21/23 17:47
6/16/23
AKROAkero Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHenderson JaneCADM.d2807.010400D
6/21/23 17:47
6/16/23
AKROAkero Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHenderson JaneCADS.d-2,16754.170-40-1000D
5/15/23 16:47
5/11/23
ISEEIveric Bio, Inc.DEHealthDrugPharmaceutical PreparationsHenderson JaneNJDM.d00.0001519522D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact